Efficacy and safety of single agent pan-HER inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer (sSCC).

Paolo Bossi,Stefano Cavalieri,Federica Perrone,Rosalba Miceli,Paolo Antonio Ascierto,Laura D. Locati,Cristiana Bergamini,Roberta Granata,Salvatore Alfieri,Carlo Resteghini,D. Galbiati,Adele Busico,Nicholas Paielli,Roberto Patuzzo,Andrea Maurichi,Gianfranco Gallino,Roberta Ruggeri,Luigi Mariani,Marco Palla,Lisa Licitra

Efficacy and safety of single agent pan-HER inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer (sSCC).

2017

9543Background: In recurrent/metastatic skin squamous cell cancer (sSCC) not amenable to radiotherapy (RT) or surgery, chemotherapy (CT) has a palliative intent and limited clinical responses. We i...

Keywords:

Skin squamous cell cancer
Oncology
Dacomitinib
Pathology
Medicine
Internal medicine
Chemotherapy
locally advanced
single agent
Radiation therapy
Palliative intent

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations